Cargando…
IDF21-0109 Coagulation Disorders in Type 2 Diabetes Mellitus Patients with COVID-19
Autores principales: | Syukur, C., Langi, Y.A., Sedli, B., Pandelaki, K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Scientific Publishers
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164593/ http://dx.doi.org/10.1016/j.diabres.2022.109315 |
Ejemplares similares
-
IDF21-0539 Can the asymptomatic COVID-19 trigger the development of diabetes mellitus?
por: Jashi, L., et al.
Publicado: (2022) -
IDF21-0533 Diabetes Mellitus in hospitalized COVID-19 patients – a retrospective cohort study
por: Çerma, A., et al.
Publicado: (2022) -
IDF21-0295 Cost-effectiveness of telemedicine care for uncontrolled type 2 diabetes mellitus patients during the COVID-19 pandemic
por: Almutairi, M., et al.
Publicado: (2022) -
IDF21-0294 Impact of COVID-19 pandemic lockdown in Spain on metabolic control of patients with type 2 diabetes mellitus
por: Cornadó-Cubells, G., et al.
Publicado: (2022) -
IDF21-0110 The role of source hypoglycemic therapy and associated diseases in patients with type 2 diabetes mellitus and COVID-19
por: Markova, T.N., et al.
Publicado: (2022)